OTC Markets OTCPK - Delayed Quote USD

PharmaCielo Ltd. (PCLOF)

0.0490

+0.0001

+(0.31%)

As of April 10 at 4:00:00 PM EDT. Market Open.

PharmaCielo Reports Q4 2024 Financial Results

PharmaCielo achieved 143% Year-Over-Year Sales Growth, Generating Year-to-Date Q4 Total Revenue of $3.54 Million.Revenues and Gross Profit Margin Increased with More Diverse Customer Base.Q4 Cash Flow Continued to Improve and Adjusted EBITDA Increased by $1.1 Million versus Last Year Reflecting Strong Sales Growth and Reduced Costs.Financial Year-End is March 31. Audited Financial Statements will be for the Fifteen-Month Period from January 1, 2024, to March 31, 2025. Toronto, Ontario and Rioneg

Newsfile last month

PCLOF
+0.31%
PharmaCielo Announces Issuance of Shares for Settlement of Certain Amounts Owing

All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - February 12, 2025) - PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced issuance of shares for settlement of certain amounts owing. Settlement of DebtToday, the Company announced

Newsfile last month

PCLOF
+0.31%
PharmaCielo Reports Q3 2024 Financial Results

PharmaCielo achieved 85% Year-Over-Year Sales Growth, Generating Year-to-Date Q3 Total Revenue of $2.4 MillionQ3 Gross Profit Turned Positive Reflecting More Diverse Customer BaseQ3 Cash Flow Improved and EBITDA Increased by $0.8 Million Reflecting Strong Sales Growth and Reduced CostsToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - December 2, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) ("PharmaCielo" or the "Company"), a global cannabis products company and Colombia's premier

Newsfile 4 months ago

PCLOF
+0.31%
PharmaCielo Announces Intention to Extend Expiry Date of Warrants

All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - November 5, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced its intention to extend expiry date of 9,007,200 warrants. Warrant Extension PharmaCielo has applied to the

Newsfile 5 months ago

PCLOF
+0.31%
PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024

All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - October 7, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today made two corporate announcements. Appointment of Davidson & Company as Auditor The Board of Directors has receive

Newsfile 5 months ago

PCLOF
+0.31%
PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2024

All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 16, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced financial results for the second quarter ended June 30, 2024. Summary Financials - Second Quarter Ended

Newsfile 7 months ago

PCLOF
+0.31%
CORRECTION FROM SOURCE: PharmaCielo Provides Update on Reinstatement for Trading

Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 17, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today provided shareholders with an update regarding reinstatement for trading on TSX Venture Exchange ("TSXV").Audit Committee AppointmentMarc Lustig, the Company's current Chairman

Newsfile 8 months ago

PCLOF
+0.31%
PharmaCielo Provides Update on Reinstatement for Trading

Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 17, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today provided shareholders with an update regarding reinstatement for trading on TSX Venture Exchange ("TSXV").Audit Committee AppointmentMarc Lustig, the Company's current Chairman

Newsfile 8 months ago

PCLOF
+0.31%
PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2023, and the First Quarter Ended March 31, 2024

All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 4, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced financial results for the fourth quarter and year ended December 31, 2023, as well as for the first quarte

Newsfile 9 months ago

PCLOF
+0.31%
PharmaCielo Announces Issuance of Failure to File Cease Trade Order

All amounts expressed in Canadian dollars unless otherwise notedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 8, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that the Ontario Securities Commission (the "OSC"), as its principal regulator, has issued a failure to file

Newsfile 10 months ago

PCLOF
+0.31%

Performance Overview

Return	PCLOF	S&P/TSX Composite index (^GSPTSE)
YTD	-9.26%	-4.37%
1-Year	-72.47%	+6.49%
3-Year	-90.98%	+8.06%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

PharmaCielo Ltd. (PCLOF)

PharmaCielo Reports Q4 2024 Financial Results

PharmaCielo Announces Issuance of Shares for Settlement of Certain Amounts Owing

PharmaCielo Reports Q3 2024 Financial Results

PharmaCielo Announces Intention to Extend Expiry Date of Warrants

PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024

PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2024

CORRECTION FROM SOURCE: PharmaCielo Provides Update on Reinstatement for Trading

PharmaCielo Provides Update on Reinstatement for Trading

PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2023, and the First Quarter Ended March 31, 2024

PharmaCielo Announces Issuance of Failure to File Cease Trade Order

Performance Overview